首页|益生菌治疗炎症性肠病的研究进展

益生菌治疗炎症性肠病的研究进展

Research Progress of Probiotics in the Treatment of Inflammatory Bowel Disease

扫码查看
炎症性肠病(IBD)是一种慢性肠道炎症疾病,发病率逐年上升,但病因尚不明确,缺少针对性好、安全性高的治疗药物.近年来,益生菌作为一种潜在的治疗策略,在IBD的预防和治疗中展现出巨大潜力.文章详细阐述了益生菌治疗IBD的机制,汇总了用于治疗IBD的常见益生菌属,并对益生菌的应用做了展望,以期为益生菌治疗IBD的研究奠定基础.
Inflammatory bowel disease(IBD)is a chronic intestinal inflammatory disease with an increasing incidence rate year by year,but its etiology is still unclear.And there is a lack of well-targeted and safe therapeutic drugs.In recent years,probiotics have shown large potential as a potential treatment strategy for the prevention and treatment of IBD.This paper elaborates on the mechanism of probiotics in the treatment of IBD,summarizes common probiotic species used in the treatment of IBD,and looks forward to the application of probiotics,aiming to lay a foundation for the research on probiotics in the treatment of IBD.

probioticsinflammatory bowel diseasetherapeutic mechanismresearch progress

耿英杰、戚浩龙、李园、蔡晓青

展开 >

山东中医药大学药学院,山东济南 250355

益生菌 炎症性肠病 治疗机制 研究进展

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(8)